Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ADM Ventures investing in microbiome

Company’s new probiotic production facility in Valencia, Spain, planned to be on line in 2022.

ADM Ventures, the corporate venture capital arm of Archer Daniels Midland (ADM), announced this week that its investing in Seventure’s Health For Life Capital (HFLC) Fund II, a leading venture capital fund dedicated to health, nutrition, microbiota and digital health.

“We view Seventure as the premier investor in microbiome startups focused on human health and nutrition, and since 2018, ADM has worked closely with the Seventure team to identify opportunities with microbiome solutions that can ultimately help with dietary supplements and food and beverage applications to serve as functional or proactive solutions,” ADM Ventures managing director Darren Streiler said. “We believe Seventure can help meet the long-term demand we see as the result of the convergence of food and pharmaceuticals and consumers looking more towards bioactives and nutrition for wellness solutions.”

The microbiome consists of trillions of micro-organisms that reside on or inside the human body. ADM’s primary interest is the vast, complex bacterial ecosystem that lives within the digestive tract and constitutes the majority of every individual’s unique microbiome.

“With a better understanding of how the microbiome ecosystem works, we can develop functional ingredients for dietary supplements and food and beverage solutions targeted to help improve overall health,” Streiler said. “We are focused on looking at new, innovative solutions that can lead to a more balanced bacterial system in your digestive tract, otherwise known as a healthy gut, and can help lead to better health.”

ADM is committed to discovering and leveraging nutritional ingredients that can be used for preventative health as well as for treating common ailments or even chronic diseases in both humans and animals. The company’s new probiotic production facility in Valencia, Spain – which will significantly increase its postbiotic and prebiotic production capacity – is planned to be on line in 2022.

TAGS: Business
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish